Stem Cell Transplant in India
Hematopoietic stem cell transplantation (HSCT) is performed at 50+ Indian centres for leukaemia, lymphoma, myeloma, aplastic anaemia, and thalassaemia. India is unique in offering haploidentical (50% HLA match) transplants at scale — expanding donor availability for all patients.
Check Your Eligibility — Free
Send your reports. Our specialists will review and confirm whether Stem Cell Transplant is right for your case.
📋 Get Free Assessment| Cost Comparison | India | USA |
|---|---|---|
| Stem Cell Transplant | $15,000–$35,000 | $150,000–$400,000 |
| Savings | 60–80% less than USA | |
Conditions Treated with Stem Cell Transplant
- Acute leukaemia (AML, ALL) — allogeneic
- Hodgkin lymphoma — autologous
- Non-Hodgkin lymphoma — autologous or allogeneic
- Multiple myeloma — autologous
- Aplastic anaemia — allogeneic
- Thalassaemia major — allogeneic (curative)
- Sickle cell disease — allogeneic
How Stem Cell Transplant Works (Step by Step)
- HLA typing and donor search
- Mobilisation (for autologous: G-CSF injections)
- Leukapheresis (stem cell collection)
- Conditioning regimen (myeloablative or reduced-intensity)
- Stem cell infusion (Day 0)
- Engraftment (Day +14 to +21)
- GVHD prophylaxis (for allogeneic)
- Long-term follow-up (immune reconstitution: 6–12 months)
Benefits of Stem Cell Transplant in India
- Haploidentical transplant removes donor scarcity barrier
- Large Indian bone marrow registry (DATRI) for unrelated donor search
- Top Indian centres match Western OS and engraftment rates
- Day 100 TRM at top centres: 5–10% for myeloablative, 3–5% for RIC
Best Hospitals for Stem Cell Transplant in India
- AIIMS, New Delhi
- Christian Medical College, Vellore
- Tata Medical Center, Kolkata
- Apollo Cancer Centre, Chennai
- Narayana Hrudayalaya, Bangalore
Frequently Asked Questions
Q: What blood disorders can be cured with stem cell transplant in India?
A: Thalassaemia major has 80–90% cure rates with allogeneic HSCT from a matched sibling at India's top centres. Sickle cell disease achieves 85–90% event-free survival. Aplastic anaemia has 80–85% long-term survival with matched sibling HSCT.